Who founded Ocugenix?

Ocugenix was founded by Sean McDonald in 2015.

How much funding has Ocugenix raised?

Ocugenix has disclosed $1.6M raised across 2 rounds.

Where is Ocugenix headquartered?

Ocugenix is headquartered in Pittsburgh, US.

Ocugenix

Pittsburgh, US · Founded 2015 · Delaware corporation

Ocugenix is a biotechnology company developing ophthalmology therapeutics based on NIH-funded research into the molecular mechanisms of wound healing and cellular response, originating from a research team at the University of Pittsburgh Medical Center. Its focus areas include eye diseases such as glaucoma and retinal conditions.

Biotech Healthtech Medical Devices

Founders & leadership

Ocugenix was founded in 2015 by Sean McDonald.

Sean McDonald inFounder · President & CEOSean McDonald is Chief Executive Officer and co-founder of Ocugenix, a biotechnology company developing therapeutics for eye diseases including glaucoma and wet macular degeneration. He previously served as President and CEO of Precision Therapeutics, where he built a personalized medicine company, and held leadership roles at McKesson and as founder of Automated Healthcare, a robotics-based pharmacy automation company.

Alan WellsChief Scientific Officer

Richard S. KollenderNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$1.6M disclosed across 2 rounds · 2019–2021

▶$1.3MraisedSep 2021 · 8 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Richard S. KollenderDirector
Sean McDonaldExecutive Officer, Director
Paul USA ChaneyDirector
Thomas C. HohmanDirector

Offering amount: $4M
Amount sold: $1.3M
First sale: Jul 2021
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$350KraisedOct 2019 · 6 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Sean McDonaldExecutive Officer, Director
Richard S. KollenderDirector

Offering amount: $350K
Amount sold: $350K
First sale: Aug 2019
Incorporated: Corporation, Delaware, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Ois11 shared keywordsOIS is a conference and community, active since 2009, focused on eye care and ophthalmology innovation, connecting startups, strategics, investors, and clinicians. It provides curated programming, networking, and access to new technologies in the ophthalmology industry.

Bioworld9 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies competing with Ocugenix for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Ocugenix do?: Ocugenix is a biotechnology company developing ophthalmology therapeutics based on NIH-funded research into the molecular mechanisms of wound healing and cellular response, originating from a research team at the University of Pittsburgh Medical Center. Its focus areas include eye diseases such as glaucoma and retinal conditions.
Who founded Ocugenix?: Ocugenix was founded by Sean McDonald in 2015.
How much funding has Ocugenix raised?: Ocugenix has disclosed $1.6M raised across 2 rounds.
Where is Ocugenix headquartered?: Ocugenix is headquartered in Pittsburgh, US.